Jan Adolfsson
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 111 publications
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.
Journal: JAMA
Published: April 06, 2024
A systematic review of hormone treatment for children with gender dysphoria and recommendations for research.
Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: January 20, 2023
Magnetic resonance imaging of the knee for chronological age estimation-a systematic review.
Journal: European radiology
Published: September 29, 2022
Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes.
Journal: JAMA network open
Published: August 08, 2022
Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data.
Journal: European urology open science
Published: July 21, 2022
Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden.
Journal: Journal of oncology
Published: June 29, 2022
Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists.
Journal: Scandinavian journal of urology
Published: May 13, 2022
The GIN-McMaster guideline tool extension for the integration of quality improvement and quality assurance in guidelines: a description of the methods for its development.
Journal: Journal of clinical epidemiology
Published: March 03, 2022
Integrating Quality Assurance and Quality Improvement With Guidelines: Systematic Stakeholder-Driven Development of an Extension of the Guidelines International Network-McMaster Guideline Development Checklist.
Journal: Annals of internal medicine
Published: February 28, 2022
Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden.
Journal: British journal of cancer
Published: January 07, 2022
Last Updated: 09/26/2026